TSH Biopharm Balance Sheet Health
Financial Health criteria checks 6/6
TSH Biopharm has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.7B and NT$224.2M respectively. TSH Biopharm's EBIT is NT$118.3M making its interest coverage ratio -10.5. It has cash and short-term investments of NT$684.2M.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | -10.5x |
| Cash | NT$684.18m |
| Equity | NT$1.51b |
| Total liabilities | NT$224.20m |
| Total assets | NT$1.74b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 8432's short term assets (NT$1.2B) exceed its short term liabilities (NT$222.3M).
Long Term Liabilities: 8432's short term assets (NT$1.2B) exceed its long term liabilities (NT$1.9M).
Debt to Equity History and Analysis
Debt Level: 8432 is debt free.
Reducing Debt: 8432 had no debt 5 years ago.
Debt Coverage: 8432 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 8432 has no debt, therefore coverage of interest payments is not a concern.